Neurofibroma - 181 Studies Found
Completed |
: Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1 :
|
Completed |
: Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas :
|
Recruiting |
: Photodynamic Therapy for Benign Dermal Neurofibromas : NEUROFIBROMATOSIS 1 : 2016-03-25 : Procedure: PDT Treatment Drug: Levulan Kerastick |
Completed |
: Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas :
|
Completed |
: Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 : Neurofibromatosis : 2008-09-16 : Drug: Pirfenidone Capsule 800 mg TID, oral |
Recruiting |
: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs) :
|
Recruiting |
: Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery :
|
Active, not recruiting |
: Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1) : Neurofibromatoses : 2012-09-05 :
|
Recruiting |
: Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain :
|
Completed |
: A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas : Neurofibromatosis Type 1 : 2008-02-20 : Drug: Sirolimus This phase II study will evaluate children and adults with neurofibromatosis type-1 (NF1 |